Associations of serologic markers of infection and inflammation with vascular disease events and mortality in American dialysis patients

被引：18
作者：
Lentine K.L. [1 ,2 ]
Parsonnet J. [3 ,4 ]
Taylor I. [5 ]
Wrone E.M. [6 ]
Lafayette R.A. [5 ]
机构：
[1] Saint Louis University Center, Outcomes Research Salus Center, St. Louis, MO 63104
[2] Division of Nephrology, Department of Medicine, Saint Louis University School of Medicine, St. Louis, MO
[3] Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA
[4] Division of Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA
[5] Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
[6] Diablo Nephrology Medical Group, Walnut Creek, CA
来源：
Clinical and Experimental Nephrology | 2006年 / 10卷 / 1期
关键词：
C-reactive protein; Cardiovascular disease; Chlamydia pneumoniae; Helicobacter pylori; Hemodialysis; Mortality;
D O I：
10.1007/s10157-005-0392-5
中图分类号：
学科分类号：
摘要：
Background. Inflammatory markers predict cardiovascular risk and mortality in endstage renal disease. The relationship of chronic infections to inflammation and vascular disease events has not been reported among American dialysis patients. Methods. We performed a cross-sectional and prospective study of a multiracial cohort of 97 chronic hemodialysis patients in California. Anti-Chlamydia pneumoniae IgA and IgG antibodies (Cp-IgA and Cp-IgG), anti-Helicobacter pylori antibodies (Hp-IgG), and highly sensitive C-reactive protein (hsCRP) levels were measured at enrollment. We ascertained the prevalence of atherosclerotic vascular (coronary artery, cerebrovascular, and peripheral vascular) disease (AVD) events, and observed participants for at least 1 year for incident events and mortality. We defined statistical significance as P < 0.01. Results. Elevated hsCRP levels (77%) and seropositivity to C. pneumoniae were common (Cp-IgA, 49%; Cp-IgG, 64%), whereas the seroprevalence of Hp-IgG was relatively low (25%). The hsCRP levels did not vary with infection status. In bivariate analysis, Cp-IgA and Cp-IgG were each associated with approximately fourfold higher odds of prevalent AVD (P < 0.01). Although anti-chlamydial antibodies maintained nearly significant associations with AVD after covariate adjustment (P < 0.05), antibodies did not predict outcomes over the period of observation. However, hsCRP was a nearly significant independent predictor of prevalent AVD (P = 0.02) and of mortality during follow-up (P = 0.01). We did not detect an association of Hp-IgG with any study outcome. Conclusions. Our findings generalize a possible link between C. pneumoniae and prevalent atherosclerosis in American hemodialysis patients and confirm the importance of hsCRP as a prognostic indicator. Our work does not support H. pylori as an important mediator of cardiovascular risk in dialysis patients. © Japanese Society of Nephrology 2006.
引用
收藏
页码：55 / 62
页数：7
相关论文
共 33 条
  • [11] Wolf S.C., Mayer O., Jurgens S., Vonthein R., Schultze G., Risler T., Et al., Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients, Clin Nephrol, 59, pp. 273-9, (2003)
  • [12] Bellomo G., Lippi G., Saronio P., Reboldi G., Verdura C., Timio F., Et al., Inflammation, infection and cardiovascular events in chronic hemodialysis patients: A prospective study, J Nephrol, 16, pp. 245-51, (2003)
  • [13] Haubitz M., Votsch K., Woywodt A., Nashan B., Groh A., Haller H., Et al., Serologic evidence of Chlamydia pneumoniae infection as a long-term predictor of cardiovascular death in renal transplant recipients, Transplantation, 77, pp. 1517-21, (2004)
  • [14] Zoccali C., Mallamaci F., Tripepi G., Parlongo S., Cutrupi S., Benedetto F.A., Et al., Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD), Kidney Int, 64, pp. 579-84, (2003)
  • [15] Naidu B.R., Ngeow Y.F., Pang T., Ethnic distribution of Chlamydophila pneumoniae antibodies in a Malaysian population and possible correlation with coronary heart disease, Eur J Epidemiol, 18, pp. 135-7, (2003)
  • [16] Fabrizi F., Martin P., Dixit V., Quan S., Brezina M., Abbey H., Et al., Epidemiology of Helicobacter pylori in chronic haemodialysis patients using the new RIBA H. pylori SIA, Nephrol Dial Transplant, 14, pp. 1929-33, (1999)
  • [17] Dowell S.F., Peeling R.W., Boman J., Carlone G.M., Fileds B.A., Guarner J., Et al., Standardizing Chlamydia pneumoniae assays: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada), Clin Infect Dis, 33, pp. 492-503, (2001)
  • [18] Verkooyen R.P., Willemse D., Hiep-Van Casteren S.C., Mousavi Joulandan S.A., Shnijder R.J., Van Den Bosch J.M., Et al., Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections, J Clin Microbiol, 36, pp. 2301-7, (1998)
  • [19] Hoymans V.Y., Bosmans J.M., Van Renterghem L., Mak R., Ursi D., Wuyts F., Et al., Importance of methodology in determination of Chlamydia pneumoniae seropositivity in healthy subjects and in patients with coronary atherosclerosis, J Clin Microbiol, 41, pp. 4049-53, (2003)
  • [20] Replogle M.L., Glaser S.L., Hiatt R.A., Parsonnet J., Biologic sex as a risk factor for Helicobacter pylori infection in healthy young adults, Am J Epidemiol, 142, pp. 856-63, (1995)
1234